Natalie A. Lockney

Management of Brain Metastases in Tyrosine Kinase Inhibitor–Naïve Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis

William J. Magnuson, N.H. Lester-Coll, Abraham J. Wu et al. · Journal of Clinical Oncology · 2017 · 448 citations

Neuro-oncology, Brain Metastases, Radiation Therapy +15

Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA)

Paul W. Sperduto, Wen Jiang, Paul D. Brown et al. · International Journal of Radiation Oncology*Biology*Physics · 2017 · 202 citations · Full text

Prognostic Evaluation, Prognostic Biomarkers, Brain Metastases +9

Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool

Paul W. Sperduto, Brian J. Deegan, Jing Li et al. · Neuro-Oncology · 2018 · 67 citations · Full text

The Prognostic Value of BRAF , C-KIT , and NRAS Mutations in Melanoma Patients With Brain Metastases

Paul W. Sperduto, Wen Jiang, Paul D. Brown et al. · International Journal of Radiation Oncology*Biology*Physics · 2017 · 65 citations

Neuro-oncology, Medicine, Prognostic Value +10

Late Toxicities of Intensity‐Modulated Radiation Therapy for Head and Neck Rhabdomyosarcoma

Natalie A. Lockney, Danielle Novetsky Friedman, Leonard H. Wexler et al. · Pediatric Blood & Cancer · 2016 · 62 citations · Full text